ロード中...
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
BACKGROUND: Several lines of evidence suggest that high-density lipoprotein (HDL) reduces Alzheimer’s disease (AD) risk by decreasing vascular beta-amyloid (Aβ) deposition and inflammation, however, the mechanisms by which HDL improve cerebrovascular functions relevant to AD remain poorly understood...
保存先:
| 出版年: | Mol Neurodegener |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7093966/ https://ncbi.nlm.nih.gov/pubmed/32213187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00366-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|